Our research and development team is an integral part of our organization, which is continuously working on the development of NOVEL DRUG DELIVERY SYSTEM (NDDS). With due assistance of our R&D team, we process and formulate a highly effective range of Pharmaceutical Pellets. The technical capabilities of our scientists further help us in manufacturing our products in accordance with the GMP and WHO-GMP quality standards. Our R&D team carries out surveys in the national and international pharmaceuticals markets, which help us to improvise our existing range of products. Our organization consistently upgrades it operational facilities that enables our formulations to meet the GMP standards. Owing to the sincere efforts of our team, we have been able to fulfill the emerging demands of national and international pharmaceuticals markets.
The NOVEL DRUG DELIVERY SYSTEM (NDDS) Research at MEDISYS BIOTECH focuses on maximizing the overall therapeutic and commercial value of commonly prescribed pharmaceutical formulations by enhancing their performance and reducing their adverse event profile. Such innovation also helps to improve the overall patient convenience and compliance. Company’s R&D has developed more than 100 SR/ CR/ ER/ MR pellets and Ready to Compress Granules. Our R &D is perhaps one of its kind working on Herbal & Nutraceuticals pellets too. R &D is led by most experienced and professionally successful scientists. Our labs are well equipped with all modern facilities.